英特格拉生命科学(IART)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IART 英特格拉生命科学

交易中 03-03 11:28:08 EST

10.15

-0.28

-2.73%

最高10.25	最低9.96	成交量16.20万
今开10.02	昨收10.43	日振幅2.78%
总市值7.90亿	流通市值6.01亿	总股本7,789万
成交额164.04万	换手率0.27%	流通股本5,927万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IART","market":"US","secType":"STK","nameCN":"英特格拉生命科学","latestPrice":10.145,"timestamp":1772555285056,"preClose":10.43,"halted":0,"volume":162038,"delay":0,"changeRate":-0.027325023969319285,"floatShares":59268124,"shares":77892111,"eps":-6.74,"marketStatus":"交易中","change":-0.285,"latestTime":"03-03 11:28:08 EST","open":10.02,"high":10.25,"low":9.9604,"amount":1640422.3181820002,"amplitude":0.027766,"askPrice":10.16,"askSize":184,"bidPrice":10.13,"bidSize":226,"shortable":3,"etf":0,"ttmEps":-6.74,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772571600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":10.43,"preHourTrading":{"tag":"盘前","latestPrice":10,"preClose":10.43,"latestTime":"09:29 EST","volume":316,"amount":3256.44004,"timestamp":1772548142084,"change":-0.43,"changeRate":-0.041227,"amplitude":0.029722},"postHourTrading":{"tag":"盘后","latestPrice":10.39,"preClose":10.43,"latestTime":"17:07 EST","volume":31436,"amount":327871.46,"timestamp":1772489267951,"change":-0.04,"changeRate":-0.003835,"amplitude":0.003835},"volumeRatio":0.552177,"impliedVol":0.5925,"impliedVolPercentile":0.494},"requestUrl":"/m/hq/s/IART","defaultTab":"news","newsList":[{"id":"1134683963","title":"英特格拉生命科学预计2026财年第一季度调整后每股收益区间为0.37至0.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134683963","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134683963?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:04","pubTimestamp":1772103856,"startTime":"0","endTime":"0","summary":"英特格拉生命科学控股公司近日发布业绩指引，预计2026财年第一季度调整后每股收益将在0.37美元至0.45美元之间。这一预测反映了公司对当期盈利能力的展望。\n该区间为投资者提供了明确的业绩预期框架，有助于市场评估公司未来财务表现。每股收益是衡量企业盈利能力的关键指标，调整后数据通常排除一次性项目影响，更能体现持续经营成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"gpt_icon":0},{"id":"1111411086","title":"英特格拉生命科学预计2026财年第一季度营收区间为3.75亿至3.90亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111411086","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111411086?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:02","pubTimestamp":1772103743,"startTime":"0","endTime":"0","summary":"英特格拉生命科学控股公司发布最新业绩指引，预计2026财年第一季度报告营收将介于3.75亿美元至3.90亿美元之间。这一预期范围反映出公司对核心业务增长的稳健展望，同时也为市场提供了衡量其短期财务表现的关键指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"gpt_icon":0},{"id":"1195167362","title":"FDA警示：英特格拉生命科学发现Medihoney伤口与烧伤产品包装缺陷，可能导致无菌屏障破坏","url":"https://stock-news.laohu8.com/highlight/detail?id=1195167362","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195167362?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:40","pubTimestamp":1769103614,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）发布公告称，医疗设备制造商英特格拉生命科学公司在其Medihoney伤口护理与烧伤治疗产品线中发现包装工艺存在缺陷。经调查确认，该缺陷可能致使产品无菌保护层受损，存在微生物污染风险。\n目前企业已启动针对性纠正措施，包括加强包装质检流程与供应链追溯体系。FDA建议医疗机构立即检查库存产品包装完整性，若发现胀包、破损或密封异常应立即停用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"gpt_icon":0},{"id":"1110894878","title":"FDA通报：英特格拉生命科学部分伤口凝胶产品存在生产与流程控制问题","url":"https://stock-news.laohu8.com/highlight/detail?id=1110894878","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110894878?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:40","pubTimestamp":1769103612,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）披露，医疗器械公司英特格拉生命科学在其部分CVS品牌伤口凝胶产品的制造与流程控制环节中发现了相关问题。\n此次发现的问题涉及生产质量控制环节，可能影响产品的一致性与安全性。FDA正与该公司合作，密切关注事态进展，并评估其对市场供应及患者使用的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"gpt_icon":0},{"id":"2605485063","title":"英特格拉生命科学盘中异动 股价大跌5.16%报11.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605485063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605485063?lang=zh_cn&edition=full","pubTime":"2026-01-21 00:06","pubTimestamp":1768925164,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日00时06分，英特格拉生命科学股票出现波动，股价急速跳水5.16%。截至发稿，该股报11.77美元/股，成交量11.3076万股，换手率0.15%，振幅3.30%。机构评级方面，在所有11家参与评级的机构中，27%的券商给予买入建议，36%的券商给予持有建议，37%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.55%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121000605a7314332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121000605a7314332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"gpt_icon":0},{"id":"1140310231","title":"英特格拉生命科学获得FDA 510(k)认证，允许在心脏手术中使用CUSA® Clarity超声外科吸引器系统","url":"https://stock-news.laohu8.com/highlight/detail?id=1140310231","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140310231?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:25","pubTimestamp":1763573133,"startTime":"0","endTime":"0","summary":"11月12日 - 英特格拉生命科学控股公司宣布，已获得FDA 510(k)认证，允许在心脏手术中使用CUSA® Clarity超声外科吸引器系统。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IART"],"gpt_icon":0},{"id":"1183679667","title":"英特格拉生命科学获得FDA 510(K)批准，可在心脏手术中使用Cusa® Clarity超声外科吸引器系统","url":"https://stock-news.laohu8.com/highlight/detail?id=1183679667","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183679667?lang=zh_cn&edition=full","pubTime":"2025-11-12 05:15","pubTimestamp":1762895719,"startTime":"0","endTime":"0","summary":"英特格拉生命科学获得FDA 510(K)批准，可在心脏手术中使用Cusa® Clarity超声外科吸引器系统","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART","BK4082"],"gpt_icon":0},{"id":"2572650698","title":"英特格拉生命科学盘中异动 早盘急速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572650698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572650698?lang=zh_cn&edition=full","pubTime":"2025-10-03 22:38","pubTimestamp":1759502290,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日22时38分，英特格拉生命科学股票出现波动，股价急速上涨5.60%。截至发稿，该股报14.75美元/股，成交量18.9208万股，换手率0.24%，振幅4.94%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为1.54%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003223810971e85bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003223810971e85bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"gpt_icon":0},{"id":"2570042668","title":"英特格拉生命科学盘中异动 急速下跌5.03%报13.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570042668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570042668?lang=zh_cn&edition=full","pubTime":"2025-09-25 22:43","pubTimestamp":1758811427,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日22时43分，英特格拉生命科学股票出现异动，股价快速跳水5.03%。截至发稿，该股报13.21美元/股，成交量12.9689万股，换手率0.17%，振幅3.74%。机构评级方面，在所有12家参与评级的机构中，25%的券商给予买入建议，42%的券商给予持有建议，33%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为1.70%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092522434797a97f66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092522434797a97f66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"gpt_icon":0},{"id":"2516376059","title":"英特格拉生命科学2024财年实现净利润-6.94百万美元，同比减少110.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376059?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758456,"startTime":"0","endTime":"0","summary":"3月1日，英特格拉生命科学公布财报，公告显示公司2024财年净利润为-6.94百万美元，同比减少110.25%；其中营业收入为16.11亿美元，同比增加4.47%，每股基本收益为-0.09美元。从资产负债表来看，英特格拉生命科学总负债24.92亿美元，其中短期债务6.22亿美元，资产负债比为1.62，流动比率为1.18。机构评级：截至2025年3月1日，当前有8家机构对英特格拉生命科学目标价做出预测，其中目标均价为26.25美元，其中最低目标价为20.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000146a2581846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000146a2581846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART"],"gpt_icon":0},{"id":"2514859090","title":"英特格拉生命科学盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859090?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:05","pubTimestamp":1740582308,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时05分，英特格拉生命科学股票出现波动，股价急速下跌5.02%。截至发稿，该股报23.48美元/股，成交量7.7221万股，换手率0.10%，振幅5.54%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.62%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230509abddf4fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230509abddf4fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"gpt_icon":0},{"id":"1186156552","title":"异动解读 | 英特格拉生命科学公司第四季度业绩好于预期,盘中股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186156552","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186156552?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:55","pubTimestamp":1740495312,"startTime":"0","endTime":"0","summary":"英特格拉生命科学公司(IART)今日盘中股价大涨5.44%,引发市场广泛关注。\n\n公司发布的最新季度财报显示,第四季度调整后每股收益为0.97美元,高于分析师预期的0.86美元。营收同比增长11.5%,达到4.4265亿美元,但仍略低于分析师预期的4.4515亿美元。\n\n由于业绩好于市场预期,尤其是调整后每股收益超出预期,这提振了投资者对公司的信心,推动股价在盘中大幅上涨。虽然营收数据略逊预期,但公司销售增长态势良好,这也是导致股价上涨的重要原因之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IART"],"gpt_icon":0},{"id":"2514180310","title":"英特格拉生命科学盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514180310?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:49","pubTimestamp":1740494947,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时49分，英特格拉生命科学股票出现异动，股价快速拉升5.44%。截至发稿，该股报23.25美元/股，成交量8.4322万股，换手率0.11%，振幅9.02%。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.44%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224907a2538b6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224907a2538b6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"gpt_icon":0},{"id":"1102458597","title":"异动解读 | 财报营收不佳、业绩预期下调 英特格拉生命科学盘前重挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102458597","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102458597?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:30","pubTimestamp":1740493821,"startTime":"0","endTime":"0","summary":"英特格拉生命科学今日盘前股价大跌5.44%,引发市场关注。首先,公司公布的第四季度营收4.426亿美元,低于分析师预期的4.451亿美元,财报营收数据不佳令投资者失望。虽然公司第四季度利润超出预期,但营收不佳引发了市场对其业绩的担忧。再者,该股在过去12个月内下跌了50.7%,股价持续下跌期间任何不利消息都可能引发投资者进一步抛售。因此,公司业绩数据不佳和下调业绩预期,引发了投资者本轮抛售情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IART"],"gpt_icon":0},{"id":"1152244544","title":"Integra Lifesciences第四季度调整后每股收益$0.97超出预期$0.86，销售额$4.4264亿低于预期$4.4515亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1152244544","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152244544?lang=zh_cn&edition=full","pubTime":"2025-02-25 19:08","pubTimestamp":1740481724,"startTime":"0","endTime":"0","summary":"Integra Lifesciences  公布季度每股收益为$0.97，高于分析师普遍预期的$0.86，增幅达到12.79%。相比去年同期每股收益$0.89，本次业绩增长了8.99%。公司季度销售额为$4.4264亿，未能达到分析师预期的$4.4515亿，差距为0.56%。以上内容来自Benzinga Earnings专栏，原文如下：Integra Lifesciences  reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.86 by 12.79 percent. This is a 8.99 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $442.64 million which missed the analyst consensus estim","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Integra Lifesciences第四季度调整后每股收益$0.97超出预期$0.86，销售额$4.4264亿低于预期$4.4515亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IART"],"gpt_icon":0},{"id":"2514772083","title":"英特格拉生命科学盘中异动 下午盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514772083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514772083?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:30","pubTimestamp":1740421840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时30分，英特格拉生命科学股票出现波动，股价急速上涨5.02%。截至发稿，该股报22.19美元/股，成交量56.2995万股，换手率0.73%，振幅4.31%。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.85%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225023041abdb4240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225023041abdb4240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"gpt_icon":0},{"id":"2511302586","title":"英特格拉生命科学盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511302586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511302586?lang=zh_cn&edition=full","pubTime":"2025-02-13 00:33","pubTimestamp":1739377997,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日00时33分，英特格拉生命科学股票出现波动，股价快速下跌5.10%。截至发稿，该股报24.37美元/股，成交量5.6238万股，换手率0.07%，振幅3.93%。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.88%。英特格拉生命科学公司简介：Integra Lifesciences Holdings Corp 是一家总部位于新泽西州的医疗设备公司，专注于开发用于再生疗法、肢体骨科和神经外科应用的产品。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213003318a2436e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213003318a2436e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"gpt_icon":0},{"id":"2505878151","title":"英特格拉生命科学盘中异动 股价大涨5.02%报25.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505878151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505878151?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:45","pubTimestamp":1737492316,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时45分，英特格拉生命科学股票出现波动，股价快速上涨5.02%。截至发稿，该股报25.31美元/股，成交量45.1258万股，换手率0.58%，振幅4.42%。机构评级方面，在所有13家参与评级的机构中，15%的券商给予买入建议，54%的券商给予持有建议，31%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为2.32%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044516960bf7c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044516960bf7c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IART"],"gpt_icon":0},{"id":"2501517092","title":"英特格拉生命科学盘中异动 早盘股价大跌5.03%报22.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501517092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501517092?lang=zh_cn&edition=full","pubTime":"2025-01-07 00:01","pubTimestamp":1736179290,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日00时01分，英特格拉生命科学股票出现异动，股价急速下挫5.03%。截至发稿，该股报22.01美元/股，成交量15.5985万股，换手率0.20%，振幅6.00%。机构评级方面，在所有13家参与评级的机构中，15%的券商给予买入建议，54%的券商给予持有建议，31%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体涨幅为0.38%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107000130a217ab42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107000130a217ab42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"gpt_icon":0},{"id":"2483851528","title":"英特格拉生命科学盘中异动 下午盘大幅下挫5.00%报23.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483851528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483851528?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:37","pubTimestamp":1731526635,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时37分，英特格拉生命科学股票出现异动，股价急速下挫5.00%。截至发稿，该股报23.57美元/股，成交量76.8216万股，换手率1.00%，振幅5.08%。机构评级方面，在所有14家参与评级的机构中，21%的券商给予买入建议，50%的券商给予持有建议，29%的券商给予卖出建议。英特格拉生命科学股票所在的医疗器械行业中，整体跌幅为0.27%。Codman 专业外科部门从其细分业务中获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033715abbe7447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033715abbe7447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IART","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.integralife.com","stockEarnings":[{"period":"1week","weight":-0.1131},{"period":"1month","weight":-0.0637},{"period":"3month","weight":-0.2074},{"period":"6month","weight":-0.3106},{"period":"1year","weight":-0.5506},{"period":"ytd","weight":-0.1602}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Integra Lifesciences Holdings Corporation于1989年在特拉华州注册成立，是一家全球领先的医疗技术公司，通过创新治疗途径来提高患者的预后，并制定外科、神经系统和再生护理的新标准。公司通过全球收购和产品开发，将基地再生技术业务扩展至包括手术器械、神经外科产品和先进的伤口护理，以满足客户不断变化的需求并增强患者护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.612903,"avgChangeRate":0.066907},{"month":2,"riseRate":0.516129,"avgChangeRate":0.02882},{"month":3,"riseRate":0.451613,"avgChangeRate":-0.014351},{"month":4,"riseRate":0.566667,"avgChangeRate":0.003985},{"month":5,"riseRate":0.466667,"avgChangeRate":-0.025427},{"month":6,"riseRate":0.566667,"avgChangeRate":0.031748},{"month":7,"riseRate":0.633333,"avgChangeRate":0.018847},{"month":8,"riseRate":0.466667,"avgChangeRate":-0.019145},{"month":9,"riseRate":0.451613,"avgChangeRate":0.000887},{"month":10,"riseRate":0.290323,"avgChangeRate":-0.030516},{"month":11,"riseRate":0.709677,"avgChangeRate":0.040359},{"month":12,"riseRate":0.548387,"avgChangeRate":0.010645}],"exchange":"NASDAQ","name":"英特格拉生命科学","nameEN":"Integra Lifesciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英特格拉生命科学(IART)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英特格拉生命科学(IART)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英特格拉生命科学,IART,英特格拉生命科学股票,英特格拉生命科学股票老虎,英特格拉生命科学股票老虎国际,英特格拉生命科学行情,英特格拉生命科学股票行情,英特格拉生命科学股价,英特格拉生命科学股市,英特格拉生命科学股票价格,英特格拉生命科学股票交易,英特格拉生命科学股票购买,英特格拉生命科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英特格拉生命科学(IART)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英特格拉生命科学(IART)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}